T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
HealthStream
HSTM
$849M
| $254K | ﹤0.01% |
11,683
+141
| +1% | +$2.81K |
|
2502
Sotera Health
SHC
$5.43B
| $254K | ﹤0.01% |
+12,956
| New | +$271K |
|
2503
Invesco Mortgage Capital
IVR
$805M
| $252K | ﹤0.01% |
17,164
+291
| +2% | +$4.92K |
|
2504
Dyne Therapeutics
DYN
$4.85B
| $251K | ﹤0.01% |
36,560
+102
| +0.3% | +$703 |
|
2505
Cass Information Systems
CASS
$750M
| $250K | ﹤0.01% |
7,389
+1,270
| +21% | +$45.6K |
|
2506
Designer Brands
DBI
$312M
| $249K | ﹤0.01% |
19,077
+41
| +0.2% | +$591 |
|
2507
MediaAlpha
MAX
$813M
| $248K | ﹤0.01% |
25,162
+312
| +1% | +$3.81K |
|
|
CONN
2508
DELISTED
Conn's Inc.
CONN
| $248K | ﹤0.01% |
30,945
-353
| -1% | -$4.64K |
|
|
EARN
2509
Ellington Residential Mortgage REIT
EARN
$167M
| $245K | ﹤0.01% |
32,812
+6,549
| +25% | +$54.2K |
|
2510
Rocket Companies
RKT
$42.6B
| $244K | ﹤0.01% |
33,191
+3,226
| +11% | +$27.9K |
|
2511
Marten Transport
MRTN
$1.24B
| $243K | ﹤0.01% |
14,455
+345
| +2% | +$5.93K |
|
|
NFBK
2512
DELISTED
Northfield Bancorp
NFBK
| $242K | ﹤0.01% |
18,603
+305
| +2% | +$4K |
|
|
AVID
2513
DELISTED
Avid Technology Inc
AVID
| $242K | ﹤0.01% |
9,344
+227
| +2% | +$6.62K |
|
2514
Barrett Business Services
BBSI
$800M
| $241K | ﹤0.01% |
13,232
+288
| +2% | +$5.29K |
|
2515
Pure Cycle
PCYO
$273M
| $241K | ﹤0.01% |
22,895
+4,231
| +23% | +$45.7K |
|
2516
SIGA Technologies
SIGA
$207M
| $241K | ﹤0.01% |
20,784
-9,792
| -32% | -$88.2K |
|
|
RFP
2517
DELISTED
Resolute Forest Products Inc.
RFP
| $241K | ﹤0.01% |
18,884
+2,184
| +13% | +$30.2K |
|
|
SPNE
2518
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $241K | ﹤0.01% |
42,591
+8,673
| +26% | +$75.6K |
|
|
BBBY
2519
DELISTED
Bed Bath & Beyond Inc
BBBY
| $240K | ﹤0.01% |
48,204
+1,963
| +4% | +$22.8K |
|
|
FSP
2520
Franklin Street Properties
FSP
$46.4M
| $239K | ﹤0.01% |
57,336
+622
| +1% | +$2.98K |
|
|
EGLE
2521
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $238K | ﹤0.01% |
4,581
+487
| +12% | +$31.2K |
|
2522
Atomera
ATOM
$212M
| $237K | ﹤0.01% |
25,285
+4,987
| +25% | +$54.9K |
|
2523
Inogen
INGN
$154M
| $236K | ﹤0.01% |
9,774
+905
| +10% | +$24K |
|
|
GTHX
2524
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $236K | ﹤0.01% |
47,765
-127,460
| -73% | -$706K |
|
2525
Oric Pharmaceuticals
ORIC
$1.42B
| $235K | ﹤0.01% |
52,439
-11,221
| -18% | -$44.8K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.